title: Ovarian cancer--can intraperitoneal therapy be regarded as new standard in Germany?
abstract: The German Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) and the two German cooperative study groups (AGO-OVAR and NOGGO) performed a review of the currently available literature on intraperitoneal first-line treatment in advanced ovarian cancer to consider if this new option should be incorporated into the German guidelines for treatment of ovarian cancer.
authors.affiliation: Department of Gynecology and Gynecologic Oncology, Dr Horst Schmidt Klinik (HSK) Wiesbaden, Germany. dubois@hsk-wiesbaden@uumail.de
authors.forename: A
authors.initials: A
authors.lastname: du Bois
authors.forename: B
authors.initials: B
authors.lastname: Schmalfeldt
authors.forename: W
authors.initials: W
authors.lastname: Meier
authors.forename: J
authors.initials: J
authors.lastname: Sehouli
authors.forename: J
authors.initials: J
authors.lastname: Pfisterer
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D002986:Clinical Trials as Topic; D005260:Female; D005858:Germany; D006801:Humans; D007263:Infusions, Parenteral / Q000379:methods*; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D017410:Practice Guidelines as Topic
chemical_list: D000970:Antineoplastic Agents